Next Generation News and Research

RSS

New TB drugs show promise with fewer side effects than linezolid

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in the treatment of drug-resistant TB.

8 Jul 2025

$New initiative at Mount Sinai enhances treatment for osteoporosis-related fractures$

New initiative at Mount Sinai enhances treatment for osteoporosis-related fractures

The Leni and Peter W. May Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai has implemented the American Orthopaedic Association's Own the Bone® program, joining more than 300 health care institutions nationwide to help better identify, evaluate, and treat patients who experience an osteoporosis- or low bone density-related fractures.

8 Jul 2025

Uncovering the hidden dangers of artificial light exposure

In a comprehensive Genomic Press Innovators & Ideas interview published today, distinguished neuroscientist Dr. Randy J. Nelson shares insights from his pioneering research on how disrupted circadian rhythms affect brain function and overall health.

8 Jul 2025

New funding brings personalized CRISPR cures closer to children with rare diseases

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

8 Jul 2025

New AI-informed method accelerates protein engineering

A team of Chinese researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences has developed a groundbreaking method that could transform the field of protein engineering.

7 Jul 2025

Innovative bispecific antibody targets LAG-3 to treat autoimmune diseases

Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune diseases.

7 Jul 2025

Reversing immune fatigue offers new hope for cancer treatment

CD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the hostile and chronic environment of tumors, these cells often falter.

7 Jul 2025

Metabolic enzyme PHGDH found to play a surprising role in breast cancer immunity

Macrophages are immune cells with a split personality: some fight tumors, while others help them grow. In breast cancer, most macrophages fall into the latter camp—dubbed M2-like—fueling tumor progression and dampening immune responses.

7 Jul 2025

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding the field of synthetic biology and the potential of living diagnostics.

From Pittcon 7 Jul 2025

Biosynth expands Berlin site with a new commercial bioconjugation suite

Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation facility at its existing Berlin site.

7 Jul 2025

Intelligent, Scalable, Precise: How n6 Is Transforming NGS Library Prep

In this interview, the team at n6 discusses their groundbreaking iconPCR thermocycler and its impact on laboratory automation, NGS data quality, and real-time control in life sciences.

From n6 7 Jul 2025

Multifunctional nanodisk enables cancer diagnosis, treatment and immune activation

The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has successfully developed a nanomaterial capable of simultaneously performing cancer diagnosis, treatment, and immune response induction.

7 Jul 2025

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers.

4 Jul 2025

$Ten-year study tracks trends in pediatric clavicle fractures across the U.S.$

Ten-year study tracks trends in pediatric clavicle fractures across the U.S.

Clavicular fractures are common injuries among children, usually due to sports-related trauma or accidental falls. The purpose of this study was to assess the epidemiology of clavicular fractures among children in the United States between 2014 and 2023.

4 Jul 2025

Mature dendritic cell vesicles enhance influenza vaccine effectiveness

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body's immune response, according to a study by researchers in the Institute for Biomedical Sciences at Georgia State University.

2 Jul 2025

Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme.

2 Jul 2025

Targeting RAP proteins for next-generation malaria treatments

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the parasite responsible for the deadliest form of human malaria, that could make novel, highly targeted anti-malarial therapies possible.

1 Jul 2025

Embryos from women with PCOS carry distinctive epigenetic memory

Novel research presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has found that embryos from women with polycystic ovary syndrome (PCOS) carry a distinctive 'epigenetic memory' that could explain why the condition often runs in families.

1 Jul 2025

Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.

30 Jun 2025

Newly discovered target may re-energize exhausted immune cells in the fight against cancer

Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or "exhausted" immune cells in their fight against cancer.

27 Jun 2025

Next Generation News and Research

New TB drugs show promise with fewer side effects than linezolid

New initiative at Mount Sinai enhances treatment for osteoporosis-related fractures

Uncovering the hidden dangers of artificial light exposure

New funding brings personalized CRISPR cures closer to children with rare diseases

New AI-informed method accelerates protein engineering

Innovative bispecific antibody targets LAG-3 to treat autoimmune diseases

Reversing immune fatigue offers new hope for cancer treatment

Metabolic enzyme PHGDH found to play a surprising role in breast cancer immunity

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

Biosynth expands Berlin site with a new commercial bioconjugation suite

Intelligent, Scalable, Precise: How n6 Is Transforming NGS Library Prep

Multifunctional nanodisk enables cancer diagnosis, treatment and immune activation

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

Ten-year study tracks trends in pediatric clavicle fractures across the U.S.

Mature dendritic cell vesicles enhance influenza vaccine effectiveness

Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Targeting RAP proteins for next-generation malaria treatments

Embryos from women with PCOS carry distinctive epigenetic memory

Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

Newly discovered target may re-energize exhausted immune cells in the fight against cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News